2016
DOI: 10.1007/s00439-016-1693-3
|View full text |Cite
|
Sign up to set email alerts
|

Impact of gene editing on the study of cystic fibrosis

Abstract: Cystic fibrosis (CF) is a chronic and progressive autosomal recessive disorder of secretory epithelial cells, which causes obstructions in the lung airways and pancreatic ducts of 70,000 people worldwide (for recent review see Cutting Nat Rev Genet 16(1):45-56, 2015). The finding that mutations in the CFTR gene cause CF (Kerem et al. Science 245(4922):1073-1080, 1989; Riordan et al. Science 245(4922):1066-1073, 1989; Rommens et al. Science 245(4922):1059-1065, 1989), was hailed as the very happy middle of a st… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
17
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 16 publications
(18 citation statements)
references
References 103 publications
(90 reference statements)
0
17
0
Order By: Relevance
“…More than 120 different mutations of the CFTR gene are known, definitely causing milder or more severe disease (2). The most abundant mutation is the ΔF508 mutation (lack of phenylalanine at position 508) (2,3).…”
mentioning
confidence: 99%
“…More than 120 different mutations of the CFTR gene are known, definitely causing milder or more severe disease (2). The most abundant mutation is the ΔF508 mutation (lack of phenylalanine at position 508) (2,3).…”
mentioning
confidence: 99%
“…However, since these enrichment strategies are not compatible with direct in vivo application of gene editing16, we decided to further characterise template-dependent editing without using a selection approach. Here, we describe a CRISPR Cas9/gRNA strategy to allow the correction of the F508del mutation and characterisation of repair tracts either side of the Cas9-induced DSB by deep sequencing.…”
mentioning
confidence: 99%
“…Although several gene/ mRNA based strategies are currently being explored and developed, they are outside the scope of this article, which focusses only on CFTR modulating small molecules; the interested reader is directed towards a recent reviews (5,6). Three main groups of small molecules are in clinical development: potentiators, correctors and read-through compounds.…”
Section: Cftr Modulatorsmentioning
confidence: 99%